The US inhalable drug market is anticipated to grow at a CAGR of 2.3% over the forecast period. The key factors that drive the growth of the industry include the increased prevalence of respiratory diseases such as asthma, COPD among others. The rising level of air pollution is one of the major factors responsible for […]
